Federal award
APPILI THERAPEUTICS USA INC.
FA70002320007
Assistance
Obligated and Ceiling
- Obligated (net)
- $11,723,272.07
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $11,723,272.07
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- APPILI THERAPEUTICS USA INC. · HREVE7N46SM8
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- —
- Awarding agency
- Department of Defense · sub-agency 5700 · office FA7000
- Funding agency
- Department of Defense · sub-agency 5700
- Assistance listing (CFDA)
- CFDA 12.800
- FAIN
- FA70002320007
- Award type code
- 05
- Actions
- 17 · May 5, 2023 to Aug 24, 2026
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History17
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Aug 24, 2026 | FY2026 | P00015 | EX | $0.00 | — |
| Jul 21, 2026 | FY2026 | P00014 | EX | $0.00 | — |
| Jul 14, 2026 | FY2026 | P00013 | EX | $0.00 | — |
| Mar 24, 2026 | FY2026 | P00012 | EX | $0.00 | — |
| Dec 5, 2025 | FY2026 | P00011 | EX | $82,694.00 | — |
| Sep 25, 2025 | FY2025 | P00010 | B1 | $0.00 | — |
| Apr 14, 2025 | FY2025 | P00009 | B1 | $0.00 | — |
| Mar 6, 2025 | FY2025 | P00008 | B1 | $0.00 | — |
| Mar 5, 2025 | FY2025 | P00007 | B1 | $0.00 | — |
| Sep 23, 2024 | FY2024 | P00006 | B1 | $700,000.00 | — |
| Aug 28, 2024 | FY2024 | P00005 | B1 | $0.00 | — |
| Jun 18, 2024 | FY2024 | P00004 | B1 | $0.00 | — |
| Jan 23, 2024 | FY2024 | ARZ999 | EX | $0.00 | — |
| Jan 23, 2024 | FY2024 | P00003 | B1 | $7,500,000.00 | — |
| Oct 24, 2023 | FY2024 | P00002 | B1 | $0.00 | — |
| Jun 28, 2023 | FY2023 | P00001 | EX | $0.00 | — |
| May 5, 2023 | FY2023 | 0 | A1 | $3,440,578.07 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.